WHWK 8-K 2026-11-09

Whitehawk Therapeutics, Inc. (WHWK) 8-K dated 2026-11-09 — accession 0001193125-26-452704.

Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.

WHWK: Whitehawk Therapeutics Reports Third Quarter 2026 Financial Results and…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported WHWK revenue for 2025-12-31 was $7.1M. Net income was -$20.6M. Revenue was down 72.5% from 2024-12-31 to 2025-12-31. WHWK currently screens at market cap $202.8M.

Not investment advice. The WHWK SEC hub lists recent forms. The stock page is the research view.